Hiroko Asanuma

3.6k total citations
63 papers, 2.6k citations indexed

About

Hiroko Asanuma is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hiroko Asanuma has authored 63 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Oncology and 23 papers in Immunology. Recurrent topics in Hiroko Asanuma's work include Immunotherapy and Immune Responses (19 papers), Cancer Cells and Metastasis (12 papers) and Sarcoma Diagnosis and Treatment (9 papers). Hiroko Asanuma is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Cancer Cells and Metastasis (12 papers) and Sarcoma Diagnosis and Treatment (9 papers). Hiroko Asanuma collaborates with scholars based in Japan, United States and Netherlands. Hiroko Asanuma's co-authors include Toshihiko Torigoe, Noriyuki Sato, Yoshihiko Hirohashi, Tadashi Hasegawa, Yasuaki Tamura, Akari Takahashi, Koichi Hirata, Kenjiro Kamiguchi, Tomohide Tsukahara and Rena Morita and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer.

In The Last Decade

Hiroko Asanuma

62 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Asanuma Japan 32 1.4k 1.2k 782 520 406 63 2.6k
Ester Fonsatti Italy 28 1.5k 1.1× 1.7k 1.4× 974 1.2× 704 1.4× 440 1.1× 64 3.3k
Ines Gütgemann Germany 25 1.1k 0.8× 1.3k 1.0× 1.2k 1.5× 332 0.6× 368 0.9× 60 3.0k
Su Yin Lim Australia 28 1.6k 1.2× 1.3k 1.0× 1.4k 1.7× 415 0.8× 474 1.2× 50 3.1k
Ann Cleverly United States 25 1.5k 1.1× 1.3k 1.1× 530 0.7× 333 0.6× 428 1.1× 54 2.6k
Oscar Krijgsman Netherlands 27 1.4k 1.1× 1.4k 1.1× 493 0.6× 426 0.8× 757 1.9× 63 2.8k
Claire Bonneau France 21 1.9k 1.4× 1.2k 1.0× 901 1.2× 450 0.9× 904 2.2× 72 3.5k
Chuanliang Cui China 28 2.0k 1.5× 1.4k 1.1× 667 0.9× 385 0.7× 377 0.9× 151 2.9k
Sanaz Memarzadeh United States 23 918 0.7× 1.1k 0.9× 345 0.4× 439 0.8× 424 1.0× 60 2.3k
Yutaka Kawakami Japan 22 915 0.7× 777 0.6× 681 0.9× 409 0.8× 305 0.8× 37 2.4k
Khalid Al‐Shibli Norway 28 1.8k 1.3× 1.3k 1.0× 916 1.2× 810 1.6× 979 2.4× 44 3.2k

Countries citing papers authored by Hiroko Asanuma

Since Specialization
Citations

This map shows the geographic impact of Hiroko Asanuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Asanuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Asanuma more than expected).

Fields of papers citing papers by Hiroko Asanuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Asanuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Asanuma. The network helps show where Hiroko Asanuma may publish in the future.

Co-authorship network of co-authors of Hiroko Asanuma

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Asanuma. A scholar is included among the top collaborators of Hiroko Asanuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Asanuma. Hiroko Asanuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tsukahara, Tomohide, Kazue Watanabe, Kenji Murata, et al.. (2019). Peptide vaccinations elicited strong immune responses that were reboosted by anti-PD1 therapy in a patient with myxofibrosarcoma. Cancer Immunology Immunotherapy. 69(2). 189–197. 4 indexed citations
3.
Sugita, Shintaro, Yasuhito Arai, Tomoyuki Aoyama, et al.. (2017). NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma. Human Pathology. 65. 225–230. 50 indexed citations
4.
Sugita, Shintaro, Hiroko Asanuma, & Tadashi Hasegawa. (2016). Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma. Diagnostic Pathology. 11(1). 37–37. 15 indexed citations
5.
Sugita, Shintaro, Yasuhito Arai, Akiko Tonooka, et al.. (2014). A Novel CIC-FOXO4 Gene Fusion in Undifferentiated Small Round Cell Sarcoma. The American Journal of Surgical Pathology. 38(11). 1571–1576. 130 indexed citations
6.
Tsukahara, Tomohide, Makoto Emori, Kenji Murata, et al.. (2014). Specific Targeting of a Naturally Presented Osteosarcoma Antigen, Papillomavirus Binding Factor Peptide, Using an Artificial Monoclonal Antibody. Journal of Biological Chemistry. 289(32). 22035–22047. 7 indexed citations
7.
8.
Takahashi, Akari, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2013). Ectopically Expressed Variant Form of Sperm Mitochondria-Associated Cysteine-Rich Protein Augments Tumorigenicity of the Stem Cell Population of Lung Adenocarcinoma Cells. PLoS ONE. 8(11). e69095–e69095. 12 indexed citations
9.
Yamamoto, Takashi, Yasuaki Tamura, Jun’ichi Kobayashi, et al.. (2013). Six-transmembrane epithelial antigen of the prostate-1 plays a role for in vivo tumor growth via intercellular communication. Experimental Cell Research. 319(17). 2617–2626. 34 indexed citations
10.
Nishizawa, Satoshi, Yoshihiko Hirohashi, Toshihiko Torigoe, et al.. (2012). HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells. Cancer Research. 72(11). 2844–2854. 101 indexed citations
11.
Miyazaki, Akihiro, Jun’ichi Kobayashi, Toshihiko Torigoe, et al.. (2010). Phase I clinical trial of survivin‐derived peptide vaccine therapy for patients with advanced or recurrent oral cancer. Cancer Science. 102(2). 324–329. 57 indexed citations
12.
Sakata, Koh‐ichi, Masanori Someya, Hiroko Asanuma, et al.. (2007). The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma. BMC Cancer. 7(1). 229–229. 12 indexed citations
13.
Tsukahara, Tomohide, Satoshi Kawaguchi, Toshihiko Torigoe, et al.. (2006). Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5. Cancer Science. 97(12). 1374–1380. 118 indexed citations
14.
Kitamura, Hiroshi, Toshihiko Torigoe, Ichiya Honma, et al.. (2006). Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: Implications for specific immunotherapy. Urology. 67(5). 955–959. 23 indexed citations
15.
Nishikawa, Noriko, Yasutoshi Kimura, Kenji Okita, et al.. (2006). Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features. Journal of Hepato-Biliary-Pancreatic Surgery. 13(4). 327–335. 13 indexed citations
16.
Yamamoto, Masaaki, Toshihiko Torigoe, Kenjiro Kamiguchi, et al.. (2005). A Novel Isoform of TUCAN Is Overexpressed in Human Cancer Tissues and Suppresses Both Caspase-8– and Caspase-9–Mediated Apoptosis. Cancer Research. 65(19). 8706–8714. 26 indexed citations
17.
18.
Kamiguchi, Kenjiro, Toshihiko Torigoe, Yoshihiko Hirohashi, et al.. (2004). Localization and function in endoplasmic reticulum stress tolerance of ERdj3, a new member of Hsp40 family protein. Cell Stress and Chaperones. 9(3). 253–253. 21 indexed citations
19.
Asanuma, Hiroko, Shuji Takahashi, Masako Ishikawa, et al.. (1999). A monoclonal antibody, 3G12, reacts with a novel surface molecule, Hal‐1, with high expression in CD30‐positive anaplastic large cell lymphomas. British Journal of Haematology. 106(1). 55–63. 5 indexed citations
20.
Takahashi, Shuji, Hiroko Asanuma, M. Okazaki, et al.. (1995). Immunohistochemical Detection of Estrogen Receptor in Invasive Human Breast Cancer: Correlation with Heat Shock Proteins, pS2 and Oncogene Products. Oncology. 52(5). 371–375. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ester Fonsatti Breakdown of academic impact, for papers by Ines Gütgemann Breakdown of academic impact, for papers by Su Yin Lim Breakdown of academic impact, for papers by Ann Cleverly Breakdown of academic impact, for papers by Oscar Krijgsman Breakdown of academic impact, for papers by Claire Bonneau Breakdown of academic impact, for papers by Chuanliang Cui Breakdown of academic impact, for papers by Sanaz Memarzadeh Breakdown of academic impact, for papers by Yutaka Kawakami Breakdown of academic impact, for papers by Khalid Al‐Shibli
Rankless by CCL
2026